Increased USP17 expression disrupted the TRAF2/TRAF3 complex formation and stabilized its target proteins, leading to elevated inflammation, stemness, and transformation ability in lung cancer cells and increased macrophage recruitment into tumors. This evidence concerns the gene USP17L9P and lung cancer.